Table 1.
Characteristics of the study population.
| The control group | the antiviral-treated group | the untreated HIV group | |
|---|---|---|---|
| n | 34 | 25 | 39 |
| Age, Median(IQR), Range, years |
38(25–61) | 39(24–62) | 38(23–63) |
| Sex Male(%) Female(%) |
|||
| 27(79.4 %) | 20(80.0 %) | 31(79.5 %) | |
| 7(20.6 %) | 5(20.0 %) | 8(20.5 %) | |
| Treatment | – | NRTI + NNRTI/PI | – |
| CD4+T cells, Median (IQR), Range, x106/L | Not determined | 345 | 249 |
| (290.5–428.0) | (178.0–358.5) |
NRTI:Nucleoside Reverse Transcriptase Inhibitor; NNRTI: Non-nucleoside Transcriptase Inhibitor; PI: Protease Inhibitor.